Excited to announce that the 3rd study from my PhD is now published in Journal of Diabetes Science & Technology 👇
https://t.co/BOhyXX2F62
The study demonstrates development of 3 ML models, incorporating SES, to predict CVD, DKD, and mortality in adults with T1D
In March’s @JMultimorbidity, @Jonesdahl et al. report a #ScopingReview (n=19) of characteristics of multidisciplinary teams in the management of patients with diabetes & comorbidities. 10 medical specialties & 5 healthcare professions were represented: https://t.co/AVWqgU3VEk
First PhD article out now in @JMultimorbidity 📰
In this study we aimed to identify and map available evidence on key characteristics of multidisciplinary teams (MDTs) within diagnosis and treatment of people with diabetes and comorbidities 🔎
https://t.co/rbIhlLg1xZ
We found that the MDTs were characterized by high heterogeneity in their outline yet seem to be both effective and cost-effective in the context of diagnosis and treatment of people with diabetes and comorbidities!
Go and check it out if interested #OpenAccess 🔓
FREE ONLINE🤩: https://t.co/a2B8MjjOpy
Our explorative study found a ⬇️ in NRS, ⬆️ in conditioned pain modulation and sleep quality after 8 weeks of ABD-exercise. ⬆️temporal summation of pain and ⬇️NRS at baseline predicted the response post-exercise (33.8%). Many Q's remain!
The last systematic review and meta-analysis in our series of papers focusing on the effectiveness of telemedicine solutions is out now! This one with focus on telemedicine in managing diabetes in pregnancy 👇
https://t.co/vPUMUKMY7S
I really had a great experience at this year’s #ATTD2022 conference listening to insightful presentations, spending time with great colleagues, and exploring the beautiful city of Barcelona 🇪🇸
@ATTDconf
Here's our next publication regarding the effectiveness of telemedicine solutions for the management of diabetes. This time with focus on T1D 👇
https://t.co/6kibzcYbcJ
Check out our latest systematic review, meta-analysis, and meta-regression on the effectiveness of telemedicine solutions for the management of type 2 diabetes here 👇
https://t.co/iv1IPDJOHp